Spatiotemporal regulation of cAMP within the cell is required to achieve receptor-specific responses. The mechanism through which the cell selects a specific response to newly synthesized cAMP is not fully understood. In hepatocyte plasma membranes, we identified two functional and independent cAMPresponsive signaling protein macrocomplexes that produce, use, degrade, and regulate their own nondiffusible (sequestered) cAMP pool to achieve their specific responses. Each complex responds to the stimulation of an adenosine G protein-coupled receptor (Ado-GPCR), bound to either A 2A or A 2B , but not simultaneously to both. Each isoprotein involved in each signaling cascade was identified by measuring changes in cAMP levels after receptor activation, and its participation was confirmed by antibody-mediated inactivation. A 2A -Ado-GPCR selective stimulation activates adenylyl cyclase 6 (AC6), which is bound to AKAP79/150, to synthesize cAMP which is used by two other AKAP79/ 150-tethered proteins: protein kinase A (PKA) and phosphodiesterase 3A (PDE3A). In contrast, A 2B -Ado-GPCR stimulation activates D-AKAP2-attached AC5 to generate cAMP, which is channeled to two other D-AKAP2-tethered proteins: guanine-nucleotide exchange factor 2 (Epac2) and PDE3B. In both cases, prior activation of PKA or Epac2 with selective cAMP analogs prevents de novo cAMP synthesis. In addition, we show that cAMP does not diffuse between these protein macrocomplexes or 'signalosomes'. Evidence of coimmunoprecipitation and colocalization of some proteins belonging to each signalosome is presented. Each signalosome constitutes a minimal functional signaling unit with its own machinery to synthesize and regulate a sequestered cAMP pool. Thus, each signalosome is devoted to ensure the transmission of a unique and unequivocal message through the cell.
Introduction
Many hormones use cAMP as a second messenger, but the cellular response to any given hormone is specific. How do cells solve this question? An initial clue to this matter was obtained 30 years ago by Buxton and Brunton [1] , who demonstrated that cardiomyocytes respond differently to stimulation by isoproterenol and prostaglandin E1 in spite of both signaling molecules use cAMP as a second messenger. The authors proposed that a given cell may have separate compartments that contain both cAMP and cAMPdependent protein kinases. Evidence of compartmentalized protein kinase A (PKA) was obtained in a study showing that type II PKA copurifies with microtubules, and that its regulatory R II subunit binds to the microtubule-associated protein, MAP2 [2] . This finding led researchers to seek additional PKA-binding proteins [3] , which came to be called 'A-kinase-anchoring proteins' (AKAPs). AKAPs were found to act as scaffolds for numerous proteins from different signaling cascades [4] [5] [6] [7] [8] [9] [10] [11] , strengthening the idea that cAMP signaling can be compartmentalized. This notion was further supported by studies showing the following: the existence of local cAMP pools [12] ; that the transduction of the signal from a b 2 -adrenergic receptor to a Ca 2+ channel occurs through a cAMP pathway that is assembled into a macrocomplex [13] ; the coordination of two integrated cAMP effector pathways in a manmade mAKAP complex, as examined using chimeric and fluorescent proteins [6] ; the regulation of nuclear PKA, as revealed by spatiotemporal manipulation of cAMP [14] ; and that the structural characteristics of PKA domains are insufficient to explain its cell signaling behavior [15] . Moreover, in a broader aspect, highorder assembled complexes are becoming a new paradigm of signal transduction [16] ; these complexes are generically denoted as 'signalosomes' as defined by Bienz: 'dynamic clusters of transducing molecules assembled typically at signal-activated receptors' [17] .
All previous information led us to hypothesize that the aforementioned macrocomplexes [6, 13] should be functionally present in cell plasma membranes, and if they are carefully prepared, proteins present in such membranes anchored to AKAPs [4] [5] [6] [7] [8] [9] [10] , might retain their orchestrated catalytic properties. If so, the activation of a membrane receptor coupled to such macrocomplexes could generate cAMP. Measurements of cAMP synthesis, cAMP degradation, and/or cAMPdependent protein activation can reflect successive steps in functional responses to an activated receptor. Thus, temporal changes in the cAMP pool should be the best natural biosensor for the detection of activated specific protein(s) from a protein macrocomplex in a signaling cascade. To increase our chances of successfully obtaining cell membrane preparations with functional macrocomplex(es), we selected the unique adenosine G protein-coupled receptor (Ado-GPCR) isotype A 2A . Previously, Zezula and Freissmuth [18] reported that A 2A -Ado-GPCR forms a tight complex with an adenylyl cyclase (AC), perhaps via the unusually long intracellular C-terminal tail that is found in A 2A -Ado-GPCR but not other adenosine receptor isotypes. Furthermore, Zhang et al. [19] recently reported the existence of a bivalent membrane-anchoring mechanism for PKA, which involves one interaction through an AKAP and another through its natural myristylated regulatory subunit, RIIb 2 . To date, four Ado-GPCRs have been described (A 1 , A 2A , A 2B , and A 3 ), each having distinctive tissue distributions, ligand affinities [20] , and transduction mechanisms [21] [22] [23] . All four adenosine receptors are present in isolated hepatocytes, where they stimulate the rates of glycogenolysis, gluconeogenesis, and ureagenesis [21] [22] [23] , and raise cytosolic [Ca 2+ ] [21, 22] . Given that A 2A -and A 2B -Ado-GPCR-based transduction systems both use cAMP [21] [22] [23] , we reasoned that the selective activation of each receptor could trigger their interactions with different signal transduction proteins to yield two detectably different cAMP pools. Indeed, in plasma membranes isolated from hepatocytes, we detected two different adenosine-responsive protein macrocomplexes or signalosomes that sequestered and exclusively used their own newly formed cAMP. Preliminary physical evidence of the existence of these signalosomes by coimmunoprecipitation and by colocalization using the confocal microscope is included. These complexes, once activated, self-regulate their own synthesis and degradation of cAMP.
Results
The activation of adenosine receptors involves specific ACs and AKAPs As expected, the addition of ATP, GTP, and Ca 2+ to isolate hepatocyte plasma membranes (HPMs) triggered the generation of cAMP via activation of both Ado-GPCRs studied here. The basal cAMP values, which were obtained from control samples (not activated by Ado-GPCR stimulation) and set as 100% in Figs 1-3 , corresponded to 26.0 AE 1.6 pmolÁmg À1 of protein (n = 16). The catalytic activity of AC is known to be inhibited by Ca 2+ and activated by Mg 2+ [24] . In our system, the suspension of HPMs in RingerKrebs containing 1.5 mM Mg 2+ was sufficient to prevent the Ca
2+
-mediated inhibition of AC. Selective activation of A 2A -Ado-GPCR was blocked by treatment with the peptide, St-Ht-31 (which disrupts the interaction between RII subunits of PKA and AKAPs [5] ), but not with the peptide St-Ht-31P (inactive control for St-Ht-31) (Fig. 1A) , and by treatment with antibodies against AKAP79/150 (encoded by AKAP5 gene according to the Human Genome Organization (HUGO) gene nomenclature committee [25] ), but not D-AKAP2 (encoded by AKAP10 gene [25] ) (Fig. 1B) or AKAP18d (encoded by AKAP7 gene [25] ) (data not shown). Above-mentioned AKAPs were tested first because its presence in liver was previously reported [26] [27] [28] .
A parallel experiment was performed to stimulate A 2B -Ado-GPCR. This receptor does not share the unique features of A 2A -Ado-GPCR [18] , although, as mentioned earlier, both receptors trigger the same physiological responses in liver cells. Stimulation of A 2B -Ado-GPCR in the presence of ATP, GTP, and Ca 2+ led to the synthesis of cAMP. This activation was blocked by antibodies against D-AKAP2 (Fig. 1C) , but not by the St-Ht-31 peptide (Fig. 1D) or antibodies against AKAP79/150 (Fig. 1C) or AKAP18d (data not shown). In a confirmatory experiment, we successfully identified D-AKAP2 and AKAP79/150 in HPMs using western blot analysis (Fig. 1E,F) . These results collectively suggest that the integrated functional response observed for A 2A -Ado-GPCRs does not rely upon its described unique feature, i.e., an unusually long intracellular Cterminal tail [18] , but instead appears to be a general property of plasma membrane GPCRs. Our results further suggest that each GPCR binds to its own multiprotein complex in the membrane. Several adenylyl cyclase isoforms are expressed in liver, but out of them, only AC5 and AC6 have been associated with specific metabolic effects modulated by hormones [29, 30] . Interestingly, increasing concentrations of antibodies against AC6 but not AC5 impaired the A 2A -Ado-GPCRdependent synthesis of cAMP ( Fig. 2A) , whereas the opposite was true for A 2B -Ado-GPCR (Fig. 2B) . The observed associations among specific GPCRs, AKAPs, PKA, and AC are not unexpected, as previous studies using other signal transduction systems reported the assemblies of AKAPs with GPCR [9,10,25], AC [4, 8, 25, 31, 32] , and PKA [2, 4, 6, 7, 9, 25, 28, [33] [34] [35] .
It is noteworthy the fact that cAMP synthesis stimulated by A 2A -or A 2B -Ado-GPCR was completely blocked if both GPCRs were simultaneously activated (Fig 1D) , resembling the cross talk phenomenon [36] , and suggesting some interaction between both complexes.
PKA is selectively activated by A 2A -Ado-GPCRs
Considering that signaling transduction proteins can colocalize and form macromolecular assemblies, we speculated that measurable catalytic activity of PKA might be expected following activation of the Ado-GPCRs. We found that PKA catalytic activity could be detected in membranes in the absence of added cAMP, if A 2A -Ado-GPCR was selectively turned on (Fig. 3A) . This was abolished by the PKA inhibitor, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89) [37] , but not by the Epac inhibitor, (4, dihydroxy-2-(6-hydroxy-1-heptenyl)- . Cyclic AMP agonists and forskolin were added simultaneously to receptor activation error bars show the SEM; *P < 0.05 and **P < 0.001, as assessed by the two-tailed Student's t-test. One-way ANOVA followed by Holm-Sidak test was performed for panel G.
4-cyclopentanecrotonic acid k-lactone) (BFA) [38] ( Fig. 3A) . In contrast, PKA activation was not observed following the selective activation of A 2B -AdoGPCRs (Fig. 3A ).
Given that mammals express different PKA isoenzymes, western blot analyses were performed to identify the specific catalytic and regulatory subunits present in HPMs. Of the PKA subunits, the a catalytic subunit (CaS), the IIa and IIb regulatory subunits (RIIaS and RIIbS) were detected in HPMs, whereas the b catalytic subunit (CbS) was not ( Fig. 3B-E) . The presence of these catalytic and regulatory subunits of PKA in liver by western blot analysis was also previously reported (e.g. [39] ).
Epac2 is selectively activated by A 2B -Ado-GPCRs
Previous reports showed that Epac can form a cAMPresponsive signaling complex with different AKAPs [6, 40, 41] , and that A 2B -Ado-GPCR stimulation in endothelial cells can trigger Epac1 activation [42] . Accordingly, we explored whether Epac was activated by AdoGPCRs in our HPM samples. In liver, regular Epac1 and Epac2 proteins are expressed in relatively low levels compared with those of other organs [43] , but a liver-specific Epac2 isoform has been reported to activate Rap1 [44, 45] . Our results revealed that stimulation of A 2B -Ado-GPCRs rather than A 2A -Ado-GPCRs, sequentially generated cAMP and activated Epac, and this step was inhibited by BFA but not by H-89 (Fig. 3G) . Rap1, the protein activated by Epac, was not added to the incubation mixture, indicating that the endogenous protein was present in the HPMs; this finding is consistent with a previous report [46] . In addition, Epac2 was identified by western blot analysis of the HPM samples (Fig. 3F) . These results showed that, in HPMs, the cAMP synthesized in response to A 2B -Ado-GPCR stimulation cannot activate PKA, whereas that synthesized in response to stimulation of A 2A -Ado-GPCR cannot activate Epac2. In HPMs, therefore, AKAP79/150, A 2A -Ado-GPCR, and AC6 appear to form a functional macromolecular complex that generates a sequestered cAMP pool for private use in activating PKA. Meanwhile, D-AKAP2, A 2B -Ado-GPCR, and AC5 form a neighboring macromolecular complex that synthesizes its own cAMP to activate Epac and Rap1. Thus, separate cAMP pools promote specific receptor responses.
Activation of PKA or Epac by cAMP analogs prevents adenosine receptor-mediated cAMP synthesis
We hypothesized that if the A 2B -Ado-GPCR and A 2A -Ado-GPCR pathways are, indeed, compartmentalized, it should be possible to separately switch them off. To test this, we used forskolin, which stimulates AC5 to generate cAMP independently of receptor participation [47] , and three cAMP analogs. As expected, forskolin generated cAMP, whereas the cAMP analogs employed in this experiment failed to trigger de novo cAMP synthesis, and were not detected by our cAMP assay (Fig. 3H) . Our results revealed that preactivation of PKA by pretreatment with its selective analog, N 6 -benzoyladenosine-cAMP (6-Bnz-cAMP) [48] , prevented A 2A -Ado-GPCR-agonist-mediated cAMP synthesis ( Fig. 3I ), while pretreatment with the Epac-selective agonist, 8-(4-chlorophenylthio)-2 0 -O-methyl-cAMP (8-pCPT-cAMP) [49] , impaired the A 2B -Ado-GPCRmediated synthesis of cAMP (Fig. 3I ). The action of dibutyryl cAMP [(Bt) 2 cAMP] was found to resemble that of 6-Bnz-cAMP, suggesting that in this experimental model, (Bt) 2 cAMP preferentially activates PKA rather than Epac (Fig. 3I ). As shown in Fig. 3I , activation of PKA or Epac triggered the selective inactivation of their corresponding A 2A -or A 2B -Ado-GPCRs. Additional studies will be required to define the mechanism underlying this inactivation, but we speculate that it may involve the sequential phosphorylation of the upstream proteins in each signaling chain (e.g., GPCRs [6, 50] and/or G protein-coupled receptor kinase) followed by the binding of b-arrestins [51] and/or ACs [4] .
Specific phosphodiesterases hydrolyze nondiffusible cAMP pools within each macromolecular complex
Phosphodiesterases (PDEs) are believed to play a major role in the creation of local cAMP pools [6] [7] [8] 10, 25, 28, [52] [53] [54] [55] . Therefore, we sought to identify the PDEs associated with the multiprotein complexes uncovered herein, and assess their roles in regulating cAMP pools. In liver, at least four different PDE are present in different compartments, but of these PDE isoforms, only PDE3s possess a transmembrane domain and are activated in vivo by hormones like insulin, glucagon, and growth hormone [56] forming membrane-associated macromolecular signaling complexes or signalosomes [52, 53, 57] . A longer incubation time and the use of antibodies against hepatic PDE3A and PDE3B showed that the antibodies against PDE3A but not PDE3B triggered the maintenance of a large cAMP pool in HPMs activated with the A 2A -Ado-GPCR agonist (Fig. 4A) . Conversely, antibodies against PDE3B but not PDE3A were associated with the maintenance of a large cAMP pool in HPMs activated with the A 2B -Ado-GPCR agonist (Fig. 4B ). This suggests that only cAMP generated by selectively activated A 2A -Ado-GPCR is accessible to the PDE3A isoform, and should be matched with AKAP79/150. Moreover, only cAMP generated by selectively activated A 2B -Ado-GPCR is accessible to the PDE3B isoform, which appears to be matched with D-AKAP2. Remarkably, our experiments showed for the first time that synthesized cAMP remained associated to the membranes following their sedimentation by light centrifugation (Fig. 4C,D) . This suggests that, along with selected isoproteins, a locally synthesized cAMP pool is bound in a highly organized manner within each AKAP-tethered protein complex, providing tight spatiotemporal control of such pools.
Interaction of signalosome proteins obtained by physical evidence
To supplement the functional evidence presented above, preliminary evidence showing the existence of protein macrocomplexes located in plasma membranes was recorded. To assess protein-interaction specificity in each signaling complex, we decided to coimmunoprecipitate specific proteins within either the proposed A 2A or A 2B protein complexes. When evaluating A 2A associations, AKAP79/150, which we propose to be specific for the protein A 2A complex, was used to precipitate the sample, then the membranes were probed for the catalytic subunit ). The volume of each withdrawn sample was replaced with an equal volume of buffer; *P < 0.001 in a comparison of the control versus the results obtained using the antibodies against PDE3A or PDE3B.
PKAa (putatively belonging to protein complex A 2A ) and for EPAC (a putative member of the A 2B complex). As expected, PKAa coimmunoprecipitated with AKAP79/ 150, while EPAC did not (Fig. 5A) . The opposite experiment, i.e., using D-AKAP2, proposed as part of the A 2B protein complex member, to precipitate the sample, resulted in coimmunoprecipitation of EPAC but not PKAa (Fig. 5B) . These results further support our proposal regarding the existence of stable, independent protein complexes transducing the signals from either the A 2A or the A 2B adenosine receptors.
Additionally, colocalization of proteins in signalosomes was investigated in highly enriched hepatocytes, either nonstimulated or selectively stimulated with adenosine agonists. Examples of colocalization of some proteins from signalosomes, ubicated in the membrane zone from nonstimulated hepatocytes, are presented in Fig. 6A . A 2A -Ado-GPCR is colocalized with AC6 and PKAa (Fig. 6A, row 1) , the latter two proteins are putative members of the A 2A signalosome. In contrast, Epac2 is colocalized with A 2B -A-Ado-GPCR, and with AC5, both proteins from A 2B complex (Fig. 6A, row 2) . From this experiment, we moved to analyze the presence of protein complexes in adenosine analogs-activated hepatocytes to reproduce the general strategy employed in our experiments, now using only two proteins from the complexes and super resolution techniques described in Experimental procedures, in order to better define their precise colocalization. Figure 6B shows the results recorded in a slide of 0.5 lm, from a stack of 13 lm. Colocalization of studied proteins was observed in control cells without stimulation. Two minutes of cell contact with the used agonists was enough to increase the mobilization and the amount of colocalized proteins. Colocalization was more general but more disorganized for the couple of proteins from the A 2A complex after activation with the A 2B agonist, than after the activation with the A 2A agonist. In the latter case, the colocalization was more focal and more precise in defined cell regions. Reciprocal behavior was recorded with the proteins from A 2B complex when activated with A 2A and A 2B agonists: more general and more disorganized colocalization when activated with the A 2A agonist than with the A 2B one, and more focal and more precise colocalization in cell regions, when activated with the A 2A agonist. In short, organization and colocalization of paired proteins in each complex within the cell was more precise and well defined by the use of the right agonist. It is feasible that signal transduction might be occurring in these defined cell regions. Hypothetically, these last results might be the physical basis of proteins interactions from different signalosomes participating in the observed cross talk (Fig. 1D) , i.e., the functional evidence of an interaction between signalosomes.
Macromolecular complexes activated by specific adenosine receptors are functional in isolated hepatocytes
We next sought to determine whether intact hepatocytes challenged with the above-listed agonists exhibited responses equivalent to those found in the HPMs. Increased rates of hepatic ureagenesis, gluconeogenesis, and glycogenolysis, plus an enhancement in [Ca 2+ ] cyt , have all been reported in isolated hepatocytes incubated with adenosine or selective agonists for Ado-GPCRs [21, 22] . These results were reproduced in (Fig. 7A-C , column 7 and Fig. 8C ). The treatment of isolated baby hamster kidney cells or RAW 264.7 macrophage cells with St-Ht-31 promoted the release of PKA from plasma membranes and the specific increase of PKA in the cytoplasm but not in plasma membranes [58] . In isolated hepatocytes, St-Ht-31 alone (as well as St-Ht-31P) did not affect glucose release or ureagenesis (Fig. 7A-C) . Our results obtained from Ht-St-31-treated cells (Fig. 7A-C) and from Ht-St-31-treated HPM (Fig. 1A) , coupled with the actions reported by Ma et al. [58] might support our general proposal that hormonal signaling is controlled by multiprotein complexes integrated into plasma membranes, rather than by single enzymes released from the complexes. Thus, the data obtained in intact isolated liver cells support the results obtained in isolated membranes, indicating the physiological significance of adenosine receptor/AKAP complexes containing sequestered cAMP pools. Finally, as observed in HPM for ACs activation (Fig. 1D) , cross talk was observed with the hepatocytes; they did not respond to the simultaneous selective activation of both A 2A -and A 2B -Ado-GPCRs (data not shown).
Discussion
This study offers an approach to better understand the extremely complex spatial organization of cAMP signaling into cell physiology. The classical approach to solve such issue had been the use of sensors that can undergo , and gluconeogenesis (C) were assessed in isolated hepatocytes treated with an Ado-GPCR agonist alone or in the presence of a PKA inhibitor (1 lM H89), an Epac inhibitor (1 lM BFA), or the St-Ht-31 peptide (1 lM). Significant differences (P < 0.001) are denoted by the lowercase letters above each bar. Equivalent data have the same letter; different letters indicate statistically significant differences (n ≥ 4).
a large conformational change upon cAMP binding, or when they are phosphorylated by PKA [59] . These probes are based on the principle of fluorescence resonance energy transfer (FRET) [59] . Sensors are protein domains which can be genetically engineered allowing optimization for FRET efficiency and spatial organization [59] . Expression of two or more FRET sensors [60] in the same cell is desirable [14] to get a simultaneous image of different steps from the signaling cascade. The results obtained with FRET technology provide sensitivity of detection plus high spatial and temporary resolution [59] . Our strategy, in contrast, combines the use of selective agonists to activate a single signaling pathway with the use of antibodies or inhibitors to block a single step in the activated pathway. This strategy overcomes accidental and undesired conformational changes in engineered proteins that might distort subtle physiological interactions among proteins participating in the integrated receptor response. Our unconventional strategy is focused on exploring the physiological interactions of proteins to integrate a receptor response at the level of cell membrane. These prepared cell membranes should be used before 30 min after their isolation; otherwise, some of the proteins hereby contained respond differently. Incubation times for the experiments were shortened as much as possible, and most of them were finished in 2 min in order to detect the initial steps of the agonists' response. Along the text, numerous reports from the literature were amalgamated with the data recorded in our experiments. Thus, synthesis of cyclic AMP triggered by activation of A 2A -or A 2B -Ado-GPCR (Fig. 1A-D) includes the stimulation of each receptor, the activation of a specific AC, and the wellknown involvement of a G protein-coupled receptor. Given the functional role of AKAPs, they are also expected to participate in the cascade. Our results reveal that disruption of this protein assembly using peptide St-Ht-31, but not its inactive control peptide St-Ht-31P (Fig. 1A) , or its specific antibody (Fig. 1B,C) can impair cAMP production. Moreover, while the AKAP79/150-coupled A 2A -Ado-GPCR specifically turns on AC6 ( Fig. 2A) , AC5 is activated only upon stimulation of D-AKAP2-coupled A 2B -Ado-GPCR ( Figs 1C and 2B ). The independent activations of these ACs suggest the existence of two separate multiprotein complexes that contain their own sequestered cAMP pools. This anchoring of a GPCR to a specific AKAP is fundamental for the generation of a specific route of signal transduction following the activation of a given receptor. In agreement with the above-mentioned functional data, results of protein coimmunoprecipitation (Fig. 5) , although not tested for all proteins, provide additional support to the existence of two independent organized macrocomplexes. In the same way, available data on protein colocalization using fluorescent antibodies indicate also the independent overlapping of proteins from the two postulated signaling macrocomplexes, as well as their mobilization and organization once cells were stimulated with adenosine analogs (Fig. 6) . ] cyt following the activation of A 2A -or A 2B -Ado-GPCRs alone (A and E) or in the presence of 1 lM H89 (B and F), or 1 lM BFA (C and G), or 1 lM St-Ht-31 peptide (D and H) (n = 3). The other experimental conditions were as reported previously [21, 22] .
The failure in cAMP synthesis when both A 2A -and A 2B -GPCR were simultaneously activated, suggest that the molecule required to activate PKA or Epac was not available. This is an interesting example of one transmembrane signaling system regulating the function of another system [36] . Since the pioneer work of Lefkowitz and Caron on cross talk [36] , they included adenylate cyclases as candidates to participate in the complex regulation of receptors function. The cross talk recorded at the level of AC5 and AC6 might be the molecular basis for the cross talk observed at the cellular level in ureagenesis, gluconeogenesis, and glycogenolysis (Results).
At the center of this response, specificity is the newly generated cAMP. Our results show that stimulation of A 2A -Ado-GPCR generates cAMP, which specifically activates PKA (Fig. 3A) and is specifically hydrolyzed by PDE3A (Fig. 4A) . This newly generated cAMP cannot activate Epac (Fig. 3G) or undergo hydrolysis by PDE3B (Fig. 4A) . Meanwhile, A 2B -Ado-GPCR activation produces cAMP that stimulates Epac (Fig. 3G) and is hydrolyzed by PDE3B (Fig. 4B) , but is unable to convey a signal to PKA (Fig. 3A) and is not hydrolyzed by PDE3A (Fig. 4B) . These results illustrate the existence of sequestered cAMP pools in each membrane protein macrocomplex. We further found that PKA and PDA3A are complexed with A 2A -Ado-GPCR and therefore with AKAP79/150, while Epac, Rap1, and PDE3B are complexed with A 2B -Ado-GPCR and hence with D-AKAP2. Interestingly, a previous report showed that PDE4D3 (a protein homolog of PDE3B) also serves as an adaptor protein for Epac [6] . Figure 9 shows a cartoon summarizing the putative functional signaling units activated by A 2A -or A 2B -Ado-GPCRs.
According to Zhang et al. [19] , it is essential that we now think in terms of 'signalosomes' rather than free regulatory and catalytic forms of PKA subunits. For this research group, a signalosome is an AKAP that recruits PKA and other signaling proteins as phosphatases and phosphodiesterases [15] . This work deals with two examples of functional signalosomes. Moreover, we observed a negative feedback loop in each complex: the selective and direct activation of PKA blocks the synthesis of cAMP in response to stimulation of A 2A -Ado-GPCR, but does not affect signaling by A 2B -Ado-GPCR (Fig. 3I) ; conversely, the activation of Epac blocks the A 2B -Ado-GPCR-mediated synthesis of cAMP, but does not affect signaling by A 2A -Ado-GPCR (Fig. 3I) . Thus, each protein complex is independently auto-regulated. As this work deals with two examples of functional signalosomes, we suggest to incorporate as important parts of these signalosomes, two components found in this work: the auto-regulated cAMP synthesis (Fig. 3I ) and the engagement of newly synthesized cAMP for its exclusive use in each signalosome (Fig. 4C,D) . These two components, together with the anchoring of GPCR by the AKAP are crucial to achieve the required functional specificity for each signalosome. In addition to our main findings, it is noticeable that the well-known cross talk phenomenon was equally observed when both, A 2A -and A 2B -AdoGPCRs, were simultaneously stimulated, either in isolated cells exhibiting physiological responses, as well as, in isolated HPM for the ACs activation (Fig. 1D) . In a recent assay, Wu wrote, with regard to GPCRs that 'lateral high-order clustering of full-length receptors seems to exist and cooperates with assembly of multiple intracellular signaling proteins into supramolecular complexes' [16] . Our results might be the first demonstration of functional GPCRs as signalosomes, which additionally sequestered cAMP. All properties described for cooperativity [61] must be inherent to these signalosomes, to make them precise molecular machines that transmit as a whole, the receptor activation signal across the cellular membrane.
The existence of sequestered cAMP pools would explain the specific responses observed following the activation of distinct receptors. It would also result in a local increase of cAMP for further activation of the signaling system, increasing the efficiency of the process. Our findings therefore suggest that future studies of the kinetic consequences of local cAMP pools are warranted.
The signalosomes described in the present work exist in an ideal and encapsulated environment where proteins can be locally (in)activated to guarantee unique and precise signal transduction. This probably occurs via (de)phosphorylation, which has been widely demonstrated for GPCRs [50] , ACs [4] , PKA [6] , and PDE [52, 53] . We postulate that the signalosomes extends beyond compartmentalized cAMP signaling [6, 34] , cAMP minipools [8], 'toolboxes' [34] , and/or pockets [33] , all of which have been proposed to explain the discriminative behavior of cAMP during cell signaling. Additionally, our present results reinforce the notion proposed from structural studies, which holds that the performance of PKA in cell signaling may be explained by its conceptual evolution from independent subunits to macromolecular complexes [15] . It is tempting to speculate that the novel signalosome conceptualized herein, comprising an GPCR, an AKAP, proteins from the signaling cascade, and a nondiffusible cAMP pool exhibiting a selfregulated synthesis, might be extended to other cells, receptors, messengers, membranes, and/or signal transduction pathways.
In summary, we report that the activated GPCR is recognized by the AKAP, where it is specifically anchored. Other proteins specifically anchored to AKAP are then successively activated to generate, use, degrade, and regulate cAMP synthesis. Under physiological conditions, cAMP does not leak from the protein macrocomplex or signalosome in which it was generated.
Experimental procedures

Chemicals
Unless otherwise noted, chemicals of the best available analytical grade were purchased from Sigma-Aldrich (Toluca, Mexico). BSA was obtained from MP Biochemicals (Solon, OH, USA). MgCl 2 was obtained from Baker (Xalostoc, Mexico). Phosphocellulose filter paper (P-81) was purchased from Whatman (Florham Park, NJ, USA), and [c 32 -P] ATP was obtained from Perkin-Elmer Life Sciences (Boston, MA, USA). The utilized primary antibodies were as follows: rabbit polyclonal antibodies raised against amino acids 508-662 in the C terminus of human D-AKAP2 (sc-98755; Santa Cruz Biotechnology (SCB), Santa Cruz, CA, USA); a mouse monoclonal antibody raised against amino acids 267-478 of rat AKAP79/150 (sc-377055; SCB); goat polyclonal antibodies raised against a peptide that maps within an internal region of mouse AKAP18d (sc-162510; SCB); goat polyclonal antibodies raised against a peptide that maps within an N-terminal cytoplasmic domain of human adenylyl cyclase (AC) 5 (sc-74300; SCB); goat polyclonal antibodies raised against a peptide that maps within an N-terminal cytoplasmic domain of human AC6 (sc-68138; SCB); rabbit polyclonal antibodies raised against a peptide that maps to the C terminus of the human PKAa catalytic subunit (sc-903; SCB); rabbit polyclonal antibodies raised against a peptide that maps to the C terminus of the human PKAb catalytic subunit (sc-904; SCB); rabbit polyclonal antibodies raised against a peptide that maps to the C terminus of the mouse PKA IIa regulatory subunit (sc-909; SCB); rabbit polyclonal antibodies raised against amino acids 21-110 of the N terminus of the human PKA IIb regulatory subunit (sc-25424; SCB); rabbit polyclonal antibodies raised against amino acids 1-300 of human PDE3A (sc-20792; SCB); rabbit polyclonal antibodies raised against amino acids 1-300 of human PDE3B (sc-20792; SCB); and a mouse monoclonal antibody raised against amino acids 1-220 of human Epac2 (sc-28326, SCB); mouse monoclonal antibodies raised against A 2A -Ado-GPCR (05-717; Millipore, Bedford, MA, USA); mouse monoclonal antibodies raised against A 2B -Ado-GPCR (AB1589P; Millipore), goat polyclonal antibodies raised against A 2B -Ado-GPCR (sc-7506; SCB). The secondary antibodies used were anti-goat Alexa 488 (SA5-10086; Invitrogen, Waltham, MA, USA); anti-rabbit Alexa 405 (A10039; Invitrogen); anti-mouse Alexa 350 (A10035; Invitrogen), and anti-mouse Alexa 488 (A-21202; Invitrogen).
Cell isolation and activation
All animal experiments were conducted according to the Federal Guidelines for Animal Care and Use (NOM 062-ZOO-1999, Secretariat of Agriculture, Mexico). The study protocol was approved by the Ethics Committee of the Facultad de Medicina, Universidad Nacional Aut onoma de M exico (UNAM). Male Wistar rats (200-250 g) were fed ad libitum a commercial diet (Purina, M exico) and given free access to water. Hepatic cells from fed or 24-h-fasted rats were isolated by collagenase digestion in a solution of 10 mM glucose dissolved in Ca 2+ -free Ringer-Krebs bicarbonate, pH 7.4 [62] . Viability was determined by the trypan blue exclusion test, and experiments were conducted when > 90% of cells excluded the dye. Hepatocytes were separated from total hepatic cells by elutriation (Centrifuge J2-21 and Rotor JE-6B; both from Beckman, Indianapolis, IN, USA) [63] . Each hepatocyte batch obtained from a single liver was suspended in 10 mL Ca 2+ -free Ringer-Krebs bicarbonate, pH 7.4. The enrichment of hepatic cells reached 99%, and was determined using a cellular marker antigen, as previously described [64] . Highly enriched hepatocytes and hepatic cell plasma membranes (see below) were selectively activated with Ado-GPCR agonists and/or antagonists in order to sustain the activation of A 2A -or A 2B -Ado-GPCRs. CGS21680 (1 lM) was used as a selective agonist for the activation of A 2A -Ado-GPCRs [65] . A mixture of NECA (1 lM; an agonist for A 1 -, A 2A -and A 2B -Ado-GPCRs [66] ) plus DPCPX (1 lM; an A 1 -Ado-GPCR-selective antagonist [67] ) was used for the activation of A 2A -and A 2B -Ado-GPCRs. In such mixture, A 1 -Ado-GPCR was inhibited by DPCPX (Ki = 0.69 nM [67] ). Detectable levels of mRNA and protein of A 1 -, A 2A -, A 2B -, and A 3 -Ado-GPCR in rat liver have been reported [68] .
Comparison of EC 50 values in rat hepatocytes previously showed that the potency of NECA to evoke glucose production was about 168-fold greater than that of the selective A 2A -Ado-GPCR agonist, CGS21680 [69] , and this can be related to the fact that expression levels of A 1 -, and A 2B -Ado-GPCR are higher than those of A 2A -, and A 3 -Ado-GPCR in rat liver [68] . Therefore, NECA plus DPCPX was herein used to activate A 2B -Ado-GPCRs in the isolated hepatocyte plasma membranes. Indeed, this mixture has been used previously to selectively activate A 2B -Ado-GPCRs in hepatic cells (e.g., [22, 23, 69] ).
Hepatic cell plasma membrane preparation
Each highly enriched hepatocyte batch from a single liver was suspended in 10 mL calcium-free Ringer-Krebs bicarbonate, pH 7.4, supplemented with 1 mL protease inhibitor cocktail (158837; MP Biochemicals). The cellular suspension was homogenized in a Teflon-glass Potter-Elvehjem homogenizer for 2 min at 4°C, and then mixed at 4°C with 100 mL of lysis buffer containing 20 mM MES [2-(Nmorpholino)ethanesulfonic acid], pH 5.8, 2 mM MgCl 2 , 1 mM CaCl 2 , and 5 mM KCl. Cell lysis was completed by vigorous mechanical shaking for 2 min. Plasma membranes were prepared in < 40 min, by differential centrifugation, as detailed in [70] . Enzyme markers were used to identify the fraction containing highly enriched hepatocyte plasma membranes (HPMs), as previously described [70] . As the catalytic activities of some enzymes present in the HPM changed by 45 min postpreparation, and the functions of the protein complexes described below were lost after 24 h of maintenance at 0°C, HPMs were used immediately after they were prepared.
Adenylyl cyclase activity
Hepatocyte plasma membranes equivalent to 20 lg protein were preincubated at 37°C for 2 min in Krebs-Ringer bicarbonate, pH 7.4, with 1.2 mM CaCl 2 , 100 lM GTP, and 1 mM ATP. They were then supplemented with 1 lM of the relevant agonist and/or antagonist for the selective activation of A 2A -or A 2B -Ado-GPCRs, and incubated for 2 min. CGS21680 (1 lM) was used as a selective agonist for the activation of A 2A -Ado-GPCRs [65] . A mixture of NECA (1 lM) plus DPCPX (1 lM) was used for the activation of A 2B -Ado-GPCRs. All inhibitors and antibodies were added to the incubation mixture 1 min prior to receptor activation. At the end of the incubation, 100 lL of 2N HCl was added to stop the reaction. The tubes were heated in a boiling water bath for 2 min, and acid was neutralized with 100 lL of 2N NaOH. Cyclic AMP was determined using a radioimmunoassay kit (TRK 432; Amersham International PLC, Amersham, UK).
Protein kinase A catalytic activity
Measurements were performed as previously described [71] . Briefly HPMs (20 lg protein in 30 lL) were mixed with 30 lL of 50 mM MOPS buffer, pH 7.0, containing 250 lgÁmL À1 bovine serum albumin, 100 lM ATP with 
Epac activation assay
Hepatocyte plasma membranes equivalent to 1 mg protein were incubated at 37°C for 2 min in Krebs-Ringer bicarbonate, pH 7.4, containing 1.2 mM CaCl 2 , 100 lM GTP, and 1 mM ATP. The cAMP required to activate Epac was generated by lighting-on the A 2A -or A 2B -AdoRs found in the HPMs. The HPMs were then immediately disrupted using the lysis buffer supplied in the Rap1 activation assay kit (17-321; Millipore), supplemented with a protease inhibitor cocktail (catalog number 158837; MP Biomedicals, Santa Ana, CA, USA). The lysate was centrifuged at 14 000 g for 5 min at 4°C, and the protein-containing supernatant was shaken for 45 min at 4°C with 30 lL of Ral GDS-RBD agarose (Millipore). The agarose beads were collected by pulse centrifugation (5 s in the microcentrifuge at 14 000 g); the supernatant fraction was discarded; and the beads were washed three times with 0.5 mL of icecold lysis buffer. The pellets were suspended in 40 lL of 29 SDS/PAGE loading buffer (100 mM Tris/HCl, pH 6.8, containing 4% sodium dodecyl sulfate, 0.2% bromophenol blue, and 20% glycerol) and 2 lL of 1 M dithiothreitol, boiled for 5 min, and subjected to western blotting. HPM lysates were electrophoresed without further processing as controls (total Rap1). Rap1 was visualized utilizing the anti-Rap1 antibody supplied with the kit. Bands were visualized using the ECL Prime Western Blotting Detection Reagent (RPN2232; Amersham-GE, Piscataway, NJ, USA). Densitometric quantifications of Rap1-GTP and total Rap1 were performed using a MultiImage Light Cabinet (Alpha Innotech, San Leandro, CA, USA).
Coimmunoprecipitation experiments
Protein A-agarose (20 lL) was incubated with 4 lg of the appropriate antibody (AKAP79/150 or D-AKAP2) for 30 min. Then, 1.5 mg of hepatocyte membrane proteins previously solubilized was added. The mixture was kept overnight at 4°C under constant agitation. Immune complexes were recovered by centrifugation (5000 g for 5 min). Then the samples were washed three times with buffer [50 mM Tris/HCl, 1 mM EDTA, pH 7.5 with 1 mM PMSF (phenylmethylsulfonyl fluoride), 0.1% Triton X-100]. The pellet was boiled for 5 min in 30 lL Laemmli's sample buffer. This sample was used for PAGE in 8% polyacrylamide-SDS and transferred to PVDF membranes. Membranes were revealed for the corresponding AKAP antibody and then stripped and reprobed with antibodies for both, EPAC and PKA. As controls we used brain and hepatocyte membrane extracts. Secondary antibodies were used as needed: D-AKAP2 was from mouse, AKAP79/150 was from goat, and EPAC and PKA were from rabbit.
Analysis by confocal microscopy
Hepatocytes were isolated as mentioned before and then resuspended in Dulbecco's modified Eagle's medium (DMEM) (GIBCO-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS), 0.02% bovine serum albumin (BSA), 3 mM Hepes, 1 mM sodium pyruvate, 0.1% galactose, insulin-transferrin-selenium, and penicillin/streptomycin. Cells were seeded on plastic Petri dishes containing coverslips coated with 1% rat-tail collagen type 1 (Becton Dickinson, Franklin Lakes, NJ, USA) and they were allowed to adhere for 12 h at 37°C in 5% CO 2 . When indicated, cells were stimulated as usual to activate A 2A -Addo-GPCR or A 2B -Ado-GPCR for 2 min to 37°C in a 5% CO 2 . Activated cells and nonactivated cells were fixed with 4% paraformaldehyde (PFA) and rinsed with phosphate-buffered saline pH 7.4 (PBS), three times with the same buffer supplemented with 0.01% Tween, and twice with the same buffer without Tween. Then cells were treated during 30 min with TSA (Tyramine System Amplification) (Perkin-Elmer Life Sciences) blocking buffer, to be incubated overnight at 4°C with the selected primary antibodies, which are indicated in each figure, dissolved in TSA-blocking buffer. In order to detect the colocalization of the bound primary antibody, a fluorescent secondary antibody directed against the IgG fraction of the primary antibody was incubated for 2 h at room temperature. Cells were rinsed with PBS as indicated before. All images were captured using a Confocal Microscope LSM 780 (Carl Zeiss Inc., Jena, Germany) using a 639/1.4 oil DIC Plan-Apochromate objective, and analyzed using ZEN LITE software from Zeiss and Image J64. Super-resolution images were captured using an ELYRA System PS1 Microscope using a 1009/1.46 oil DIC VIS Plan-Apocromat objective (Carl Zeiss Inc.), and analyzed with Structure Illumination Method (SIM) software from ZEN and Image J64.
Determination of free cytosolic calcium in isolated hepatocytes
Hepatocytes were loaded with Fura-2AM as described by Llopis et al. [72] . Briefly, hepatocytes were suspended in 1 mL Ringer-Krebs bicarbonate supplemented with 1.2 mM CaCl 2 to a final concentration of 40 mg w/w per mL. After incubation for 20 min, 5 lM Fura-2AM (from a 10 mM stock solution in dimethyl-sulfoxide) was added. After a further incubation for 20 min, the cells were rinsed twice in a clinical centrifuge (2700 g, 1 min). The hepatocytes were then divided into 200-lL aliquots (4 9 10 5 cells/ aliquot) in Eppendorf microfuge tubes and immersed in ice, and within the next 3 min, [Ca 2+ ] cyt was measured as previously described [73] , using K d = 224 nM.
Metabolic activity assays
Gluconeogenesis: hepatocytes (5 9 10 5 cells) from a 24-hstarved rat were incubated in 1-mL glucose-free RingerKrebs bicarbonate containing 10 mM lactate, at 37°C in an atmosphere of 95% O 2 /5% CO 2 (this temperature and atmosphere was used for the incubation of cells unless otherwise specified) for 60 min with continuous shaking. The tubes were then placed in ice-cold water, and the glucose formed was measured by the glucose oxidase method [74] . Glycogenolysis: hepatocytes from rats fed ad libitum were incubated as described before, but without lactate and for 45 min. Glucose was measured as indicated before.
Urea synthesis: hepatocytes (5 9 10 5 cells) from 24-hstarved rats were incubated for 1 h with continuous shaking in 1 mL Ringer-Krebs bicarbonate supplemented with 10 mM glucose, 5 mM ammonium carbonate, and 3 mM ornithine. At the end of incubation, urea was determined as previously described [75] .
Western blot analysis
Brains, hepatocytes, and HPMs were disrupted in lysis buffer (1% NP-40 and 1 mM EDTA in phosphate-buffered saline) containing a protease inhibitor mixture (158837; MP Biomedicals), with shaking for 30 min at 4°C. Solubilized proteins were centrifuged at 14 000 g at 4°C for 10 min, and the proteins in the supernatant were quantified by the Bradford method and used as the soluble extract [76] . Proteins were resolved by SDS/PAGE and transferred onto a polyvinylidene fluoride membrane (PVDF; Millipore) using a Tank Transfer System (Bio-Rad, Hercules, CA, USA) at 100 V for 1 h. Membranes were blocked overnight at 4°C with Tris-buffered saline containing 5% nonfat dry milk and 0.1% Tween 20. Blots were incubated with commercially available antibodies. The blots were incubated with a horseradish peroxidase-conjugated secondary antibody, and the protein bands were visualized by chemiluminescence (ECL Plus; GE Healthcare, Little Chalfont, Buckinghamshire, UK). A soluble extract of rat brain was used as the positive control.
Data analysis and presentation
Unless otherwise indicated, the results presented are the average AE the SE of the mean (SEM) obtained from at least four independent experiments performed in duplicate. For immunoblots, one result representative of at least three independent experiments is shown. 
